1. Felker G. M. , Thompson R. E. , Hare J. M. , et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med, 342 (2000), pp. 1077–1084. http: //dx. doi. org/10. 1056/NEJM200004133421502, Felker G. M. , Thompson R. E. , Hare J. M. , et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med, 342 (2000), pp. 1077–1084. http: //dx. doi. org/10. 1056/NEJM200004133421502
2. O'Hare M, Sharma A. , Murphy K. , et. al. Cardio-oncology Part I: chemotherapy and cardiovascular toxicity. Expert Rev Cardiovasc Ther. 2015 Apr 5: 1-8. http: //dx. doi. org/10. 1586/14779072. 2015. 1027686, O'Hare M, Sharma A. , Murphy K. , et. al. Cardio-oncology Part I: chemotherapy and cardiovascular toxicity. Expert Rev Cardiovasc Ther. 2015 Apr 5: 1-8. http: //dx. doi. org/10. 1586/14779072. 2015. 1027686
3. Truong J, Yan A. T. ,Cramarossa G. et. al. Chemotherapy-induced cardiotoxicity: detection, prevention, and management. Can J Cardiol. 2014 Aug;30 (8): 869-78. doi: 10. 1016/j. cjca. 2014. 04. 029., Truong J, Yan A. T. ,Cramarossa G. et. al. Chemotherapy-induced cardiotoxicity: detection, prevention, and management. Can J Cardiol. 2014 Aug;30 (8): 869-78. doi: 10. 1016/j. cjca. 2014. 04. 029.
4. Cardinale, D. , Colombo, A. , Torrisi, R. , Sandri, M. T. , Civelli, M. , Salvatici, M. et al. Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation. J Clin Oncol. 2010
5. 28: 3910-3916. doi: 10. 1200/JCO. 2009. 27. 3615., Cardinale, D. , Colombo, A. , Torrisi, R. , Sandri, M. T. , Civelli, M. , Salvatici, M. et al. Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation. J Clin Oncol. 2010